Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Net loss $ (750,580) $ (913,376)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense included in - General and administrative costs 5,681
Stock-based compensation expense included in - Research and development costs 16,060
(Increase) decrease in -    
Advances on research and development contract services 181,329
Prepaid expenses and other current assets 15,537 19,719
Increase (decrease) in -    
Accounts payable and accrued expenses (36,160) 41,498
Research and development contract liabilities 1,450 (18,341)
Net cash used in operating activities (769,753) (667,430)
Cash flows from financing activities:    
Proceeds from sale of common stock 2,500,000
Net cash provided by financing activities 2,500,000
Cash:    
Net increase (decrease) (769,753) 1,832,570
Balance at beginning of period 1,305,748 199,929
Balance at end of period 535,995 2,032,499
Supplemental disclosures of cash flow information:    
Interest
Income taxes